DCF Analysis Puts Veeva Intrinsic Value at $173 vs $319 Price, Deepening Overvaluation Concerns

What happened

On October 21, 2026, GuruFocus published a DCF analysis indicating Veeva Systems' intrinsic value is $173 per share, while the stock traded at $319, implying severe overvaluation. This follows a 42.8% year-to-date gain in Veeva's share price, a sharp rally from the $197.40 level recorded in the DeepValue master report dated July 16, 2026. Veeva's underlying fundamentals remain strong, with Q1 FY27 revenue up 16% year-over-year to $882.9 million, $7.3 billion in cash, and Vault CRM live customers exceeding 150, though subscription gross margin slipped to 86% and competition from Salesforce persists. The DCF's lower intrinsic value likely reflects more conservative growth or higher discount rate assumptions, consistent with the master report's cautious stance that the market is pricing in flawless execution. At $319, the stock trades far above the master report's bull case of $235 and its trim-above level of $225, reinforcing a clear overvaluation signal.

Implication

The DCF analysis and the master report both suggest Veeva's stock is trading well above its fundamental fair value, with the master report's wait rating and trim-above level of $225 now significantly breached at $319. The risk-reward is skewed to the downside, as the current price embeds optimistic assumptions about Vault CRM migration, AI monetization, and sustained growth that have yet to be proven. Investors should monitor key checkpoints such as quarterly Vault CRM adds exceeding 20, the August 2026 Vault AI expansion, and the November 2026 Falcon early-adopter release, as these will validate or undermine the premium multiple. While the $7.3 billion cash balance and high margins provide balance-sheet support, they do not justify paying over 45 times earnings when growth is expected to decelerate. Patience is warranted; a meaningful correction toward the $180-$225 range would offer a more attractive entry point for long-term investors.

Thesis delta

The thesis shifts from a 'wait' stance to a stronger cautionary position due to the stock's dramatic appreciation to $319, which far exceeds even the bullish scenario of $235 in the master report. The new DCF valuation of $173, while relying on its own assumptions, provides a concrete anchor below the master report's base case and reinforces the view that the market is overpaying for execution that has yet to fully materialize. Core fundamentals remain solid, but the absence of margin of safety at current prices and the persistent transition risks argue for avoiding new positions and trimming existing ones.